Clinical Trial Update: The Predictive Value of Proteome Profiling for Brain Metastasis in Limited-Stage Small-Cell Lung Cancer

View source ↗

Summary

Updates on a clinical trial assessing whether proteome profiling can predict brain metastasis in patients with limited-stage small-cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Snippet

Sponsor: Jinming Yu | Conditions: Small-cell Lung Cancer | Status: ACTIVE_NOT_RECRUITING